The New Era of Hepatitis C Virus Therapy

The hepatitis C virus (HCV) has a significant medical and economic impact on societies around the world, and it has been estimated that 130-180 million people are infected with HCV. Therapies for HCV are currently undergoing a revolution. In recent years, several new treatments have been approved by...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Judaibi, Bandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707801/
https://www.ncbi.nlm.nih.gov/pubmed/26655128
http://dx.doi.org/10.4103/1319-3767.170947
_version_ 1782409374254235648
author Al-Judaibi, Bandar
author_facet Al-Judaibi, Bandar
author_sort Al-Judaibi, Bandar
collection PubMed
description The hepatitis C virus (HCV) has a significant medical and economic impact on societies around the world, and it has been estimated that 130-180 million people are infected with HCV. Therapies for HCV are currently undergoing a revolution. In recent years, several new treatments have been approved by the United States Food and Drug Administration, and many other treatments are in phase II or III clinical trials, including direct antiviral agents (DAAs). Due to recent major advances in the field of HCV therapy, a summary of findings on new HCV therapies are provided in this review article, including reports on new DAAs.
format Online
Article
Text
id pubmed-4707801
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-47078012016-01-25 The New Era of Hepatitis C Virus Therapy Al-Judaibi, Bandar Saudi J Gastroenterol Review Article The hepatitis C virus (HCV) has a significant medical and economic impact on societies around the world, and it has been estimated that 130-180 million people are infected with HCV. Therapies for HCV are currently undergoing a revolution. In recent years, several new treatments have been approved by the United States Food and Drug Administration, and many other treatments are in phase II or III clinical trials, including direct antiviral agents (DAAs). Due to recent major advances in the field of HCV therapy, a summary of findings on new HCV therapies are provided in this review article, including reports on new DAAs. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4707801/ /pubmed/26655128 http://dx.doi.org/10.4103/1319-3767.170947 Text en Copyright: © Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Al-Judaibi, Bandar
The New Era of Hepatitis C Virus Therapy
title The New Era of Hepatitis C Virus Therapy
title_full The New Era of Hepatitis C Virus Therapy
title_fullStr The New Era of Hepatitis C Virus Therapy
title_full_unstemmed The New Era of Hepatitis C Virus Therapy
title_short The New Era of Hepatitis C Virus Therapy
title_sort new era of hepatitis c virus therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707801/
https://www.ncbi.nlm.nih.gov/pubmed/26655128
http://dx.doi.org/10.4103/1319-3767.170947
work_keys_str_mv AT aljudaibibandar theneweraofhepatitiscvirustherapy
AT aljudaibibandar neweraofhepatitiscvirustherapy

Ejemplares similares